how often should you take glp-1 Chart: 1 in 8 Americans Now Use Drugs for Weight Loss GLP-1 receptor agonists | How

PLoS One 10:e0119034

And just as our understanding of the etiology and treatment of depression has evolved, so has our understanding of obesity evolved in a parallel fashion

Retatrutide is a triple agonist that activates three receptors: GLP-1, GIP, and Glucagon

124,125,126 The design concept of these multi-agonists is to simultaneously regulate multiple key metabolic pathways to achieve more effective control over blood sugar, body weight, and overall metabolic health

Pep tracks both injectable and oral GLP-1 medications, so it fits weekly shots like Ozempic, Wegovy, Mounjaro, and Zepbound as well as daily options like Rybelsus and the Wegovy pill

Some options on the market under FDA-approval include Wegovy, Saxenda, and Zepbound